Search results for "FDA update"
New drug treats cancer based on biomarker, not location
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/07/new-drug-treats-cancer-based-on-biomarker-not-location.htm
1 Jul 2017
First drug approved for tardive dyskinesia
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/06/fda.htm
1 Jun 2017
Layout 1
Note: The FDA states that drugs are notalways commercially available immediatelyafter approval.A. ... First drug approved for tardive dyskinesiaBy Mollie Durkin. Practice Tips. FDA Update.
https://immattersacp.org/archives/2017/06/acpi-201706-tips_t1.pdf
24 May 2017
Warning on IBS drug for patients without gallbladders
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/05/fda.htm
1 May 2017
Warning on rare but serious allergic reactions to antiseptic
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/04/fda.htm
1 Apr 2017
Warning about cybersecurity; constipation drug approved
This column reviews details on recent recalls, warnings, and approvals.
https://immattersacp.org/archives/2017/03/fda.htm
1 Mar 2017
Label change for pioglitazone-containing medications
This column reviews a label change for medicine that contain pioglitazone and a new indication for empagliflozin.
https://immattersacp.org/archives/2017/02/fda.htm
1 Feb 2017
Warning on steroids; approval for soft-tissue sarcoma drug
This column reviews a warning on testosterone and other anabolic androgenic steroids and approval of a new drug to treat certain adults with soft-tissue sarcoma.
https://immattersacp.org/archives/2017/01/fda-update.htm
1 Jan 2017
New warnings for opioids; approval for arthritis drug
This column reviews a warning on opioid pain drugs and cough medicines combined with benzodiazepines and approval of a new drug to treat multiple inflammatory diseases.
https://immattersacp.org/archives/2016/11/fda.htm
1 Nov 2016
Updated warnings on fluoroquinolones, new diabetes drug
This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://immattersacp.org/archives/2016/10/fda.htm
1 Oct 2016